Delyon J - Search Results

1

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors.

Roger A, Groh M, Lorillon G, Le Pendu C, Maillet J, Arangalage D, Tazi A, Lebbe C, Baroudjian B, Delyon J; PATIO group. Roger A, et al. Among authors: delyon j. Ann Rheum Dis. 2019 Aug;78(8):e82. doi: 10.1136/annrheumdis-2018-213857. Epub 2018 Jun 23. Ann Rheum Dis. 2019. PMID: 29936437 No abstract available.

2

[Clinical and biological heterogeneity of melanomas].

Delyon J, Mourah S, Lebbé C. Delyon J, et al. Rev Prat. 2014 Jan;64(1):72-3. Rev Prat. 2014. PMID: 24649551 Review. French. No abstract available.

3

EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells.

Delyon J, Khayati F, Djaafri I, Podgorniak MP, Sadoux A, Setterblad N, Boutalbi Z, Maouche K, Maskos U, Menashi S, Lebbé C, Mourah S. Delyon J, et al. Exp Dermatol. 2015 Jun;24(6):443-8. doi: 10.1111/exd.12693. Epub 2015 Apr 16. Exp Dermatol. 2015. PMID: 25807898

4

The ipilimumab lesson in melanoma: achieving long-term survival.

Delyon J, Maio M, Lebbé C. Delyon J, et al. Semin Oncol. 2015 Jun;42(3):387-401. doi: 10.1053/j.seminoncol.2015.02.005. Epub 2015 Feb 17. Semin Oncol. 2015. PMID: 25965357 Review.

5

Validation of a preclinical model for assessment of drug efficacy in melanoma.

Delyon J, Varna M, Feugeas JP, Sadoux A, Yahiaoui S, Podgorniak MP, Leclert G, Dorval SM, Dumaz N, Soulie J, Janin A, Mourah S, Lebbé C. Delyon J, et al. Oncotarget. 2016 Mar 15;7(11):13069-81. doi: 10.18632/oncotarget.7541. Oncotarget. 2016. PMID: 26909610 Free PMC article.

6

PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.

Delyon J, Servy A, Laugier F, André J, Ortonne N, Battistella M, Mourah S, Bensussan A, Lebbé C, Dumaz N. Delyon J, et al. Oncogene. 2017 Jun 8;36(23):3252-3262. doi: 10.1038/onc.2016.469. Epub 2017 Jan 16. Oncogene. 2017. PMID: 28092671

7

Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors.

Arangalage D, Delyon J, Lermuzeaux M, Ekpe K, Ederhy S, Pages C, Lebbé C. Arangalage D, et al. Among authors: delyon j. Ann Intern Med. 2017 Nov 7;167(9):683-684. doi: 10.7326/L17-0396. Epub 2017 Sep 5. Ann Intern Med. 2017. PMID: 28869988 No abstract available.

8

Transient pituitary ACTH-dependent Cushing syndrome caused by an immune checkpoint inhibitor combination.

Lupu J, Pages C, Laly P, Delyon J, Laloi M, Petit A, Basset-Seguin N, Oueslati I, Zagdanski AM, Young J, Bouche C, Lebbé C, Gautier JF. Lupu J, et al. Among authors: delyon j. Melanoma Res. 2017 Dec;27(6):649-652. doi: 10.1097/CMR.0000000000000405. Melanoma Res. 2017. PMID: 29036015

9

PD-1 blockade with nivolumab in endemic Kaposi sarcoma.

Delyon J, Bizot A, Battistella M, Madelaine I, Vercellino L, Lebbé C. Delyon J, et al. Ann Oncol. 2018 Apr 1;29(4):1067-1069. doi: 10.1093/annonc/mdy006. Ann Oncol. 2018. PMID: 29324995 Free article. No abstract available.

10

Enteritis without colitis in patients treated with immune checkpoint inhibitors: a tricky diagnosis.

Sokal A, de Chou CS, Delyon J, Roche B, Lourenco N, Lebbé C, Baroudjian B; PATIO group. Sokal A, et al. Among authors: delyon j. Melanoma Res. 2018 Oct;28(5):483-484. doi: 10.1097/CMR.0000000000000484. Melanoma Res. 2018. PMID: 30148767 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters